» Articles » PMID: 25446556

Endothelial Dysfunction and Lung Capillary Injury in Cardiovascular Diseases

Overview
Date 2014 Dec 3
PMID 25446556
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac dysfunction of both systolic and diastolic origins leads to increased left atrial pressure, lung capillary injury and increased resistance to gas transfer. Acutely, pressure-induced trauma disrupts the endothelial and alveolar anatomical configuration and definitively causes an impairment of cellular pathways involved in fluid-flux regulation and gas exchange efficiency, a process well identified as stress failure of the alveolar-capillary membrane. In chronic heart failure (HF), additional stimuli other than pressure may trigger the true remodeling process of capillaries and small arteries characterized by endothelial dysfunction, proliferation of myofibroblasts, fibrosis and extracellular matrix deposition. In parallel there is a loss of alveolar gas diffusion properties due to the increased path from air to blood (thickening of extracellular matrix) and loss of fine molecular mechanism involved in fluid reabsorption and clearance. Deleterious changes in gas transfer not only reflect the underlying lung tissue damage but also portend independent prognostic information and may play a role in the pathogenesis of exercise limitation and ventilatory abnormalities observed in these patients. Few currently approved treatments for chronic HF have the potential to positively affect structural remodeling of the lung capillary network; angiotensin-converting enzyme inhibitors are one of the few currently established options. Recently, more attention has been paid to novel therapies specifically targeting the nitric oxide pathway as a suitable target to improve endothelial function and permeability as well as alveolar gas exchange properties.

Citing Articles

Evaluating cardiac function with chest computed tomography in acute ischemic stroke: feasibility and correlation with short-term outcome.

Bao J, Wang C, Zhang Y, Su Z, Du X, Lu J Front Neurol. 2023; 14:1173276.

PMID: 37475736 PMC: 10354548. DOI: 10.3389/fneur.2023.1173276.


Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis.

Wu X, Zhang N, Li J, Yang Z, Huang X, Yang X Purinergic Signal. 2022; 19(1):265-272.

PMID: 34981330 PMC: 9984579. DOI: 10.1007/s11302-021-09839-x.


Pulmonary vasodilator use in continuous-flow left ventricular assist device management.

Pirlamarla P, Rame E, Hoopes C, Rajapreyar I Ann Transl Med. 2021; 9(6):522.

PMID: 33850919 PMC: 8039680. DOI: 10.21037/atm-20-4710.


Role of Farnesoid X Receptor in the Pathogenesis of Respiratory Diseases.

Wu J, Chen J, Chen J Can Respir J. 2020; 2020:9137251.

PMID: 33294085 PMC: 7714608. DOI: 10.1155/2020/9137251.


The dilemma of renin-angiotensin system inhibitors in coronavirus disease 2019 (COVID-19): insights into lung fluid handling and gas exchange in heart failure patients.

Guazzi M, Moroni A Eur J Heart Fail. 2020; 22(6):926-928.

PMID: 32438449 PMC: 7280634. DOI: 10.1002/ejhf.1910.